Founded on a simple premise: the failures of solid-tumour cell therapy are engineering problems, and engineering problems can be solved deliberately.
Gaisce began as a spinout from the University of Galway in partnership with IMPACT, drawing on a research collaboration spanning Galway and Düsseldorf. The name reflects the ambition and the discipline: a great feat, approached as a sequence of engineering decisions rather than a single bet.
We are pre-clinical, and we intend our public language to stay measured and evidence-grounded. Mechanism detail stays behind the data room until filed; what we publish here is the what, the benefit, and the bar we hold ourselves to.
